AMR is a critical global public health concern, but attempts to contain it have fallen short, partly due to weak incentives for pharmaceutical companies to develop new antibiotics, and the overuse of antibiotics in humans and animals. At a UN General Assembly High-Level Meeting in September 2024, global leaders reviewed the progress made on AMR and discussed ways to accelerate efforts to combat this issue.
The meeting resulted in the adoption of an extended Political Declaration. Key commitments included reducing the human deaths associated with AMR by 10% by 2030, securing sustainable financing for national action plans on AMR, developing alternative treatments such as vaccines, and promoting responsible use in animal health.
The High-Level Meeting also emphasised the need for cross-national and cross-industry collaboration in combatting AMR. This presents a pivotal opportunity for governments, investors, and companies to reassess their current practices and strategically plan how they can help to achieve the commitments adopted at the meeting.
EOS at Federated Hermes Limited has been engaging with companies and policymakers on this issue since 2017. In our interactions with companies, we aim to elevate discussions on AMR to the board level and advocate for robust governance of these risks, as we believe this will have a positive effect on each company’s financial performance.
To find out more, read the full article in our Q2 2025 Public Engagement Report.
Accelerating action on AMR
Share:
EOS001420
